cancer treatments | e-Asfalistiki
Poland: EIB to support Ryvu Therapeutics’ discovery, research and development of new cancer treatments with €22 million
Ryvu Therapeutics, an innovative biotech company, receives EIB financing to accelerate the development of new therapies to treat severe blood cancers and solid tumours, including further clinical development of the…